|
The global market for stem cell products and services is forecast to grow almost threefold by 2010 and stem cell research continues to make significant advances towards valuable medical treatments. Despite these advances, the development of stem cell products remains a virtually untapped profit centre. The 3rd annual European Stem Cells & Regenerative Medicine Congress focuses on bridging these gaps between researchers, investors and manufacturers. The focus is both scientific and commercial. This 3-day event will represent the pioneering work being conducted by 50 of the world's most respected research and commercial organisations.
The congress has been shaped to appeal to senior level executives, providing you with the resources, information and advice you need to aid your research, strategic business planning, decision making and your future professional development.
» Register now
» Download the conference brochure
“Great cross section of vaccine science, excellent speakers, well organised format. I would definitely recommend.” Annie DeGroot, CEO, EpiVax
|
This year's speakers include:
|
 Dr Alan Trounson
President
California Institute of Regenerative Medicine
|
 Mr Bernard Siegel Executive Director
Genetics Policy Institute |
 Dr Thomas Okarma Chief Executive Officer
Geron |
 Dr Gail Naughton
Chief Executive Officer
Histogen |
|
 Dr Eric Lagasse
Professor, Department of Pathology and Director of the Cancer Stem Cell Center
McGowan Institute for Regenerative Medicine
|
|
 Dr. Michael West
Chief Executive Officer
Biotime
|
|
